MORE►
National Institues of Health
Dr. Suchismita Acharya, co-founder and CEO of AyuVis [Photo: AyuVis]
Fort Worth’s AyuVis Receives $2.1M NIH Grant for Clinical Trial of New-Gen Immunotherapies
by Lance Murray | May 17, 2023
The grant from the National Heart, Lung, and Blood Institute will fund a first-in-human Phase 1 clinical trial of a new generation of immunotherapies. This is the fourth NIH grant AyuVis has received since its founding in 2014, doubling total non-dilutive funding to $4.2 million. Co-Founder and CEO Dr. Suchismita Acharya calls the move to a human trial "a huge milestone for AyuVis."
by Lance Murray |
Mar 7, 2023
Researchers at UT Southwestern Medical Center in Dallas have discovered that could lead to an effective treatment for acute alcohol intoxications.
The researchers reported in a new study that a shot of a liver-produced hormone called FGF21 sobered up mice that had passed out from alcohol....
MORE►
by Lance Murray |
Jan 17, 2020
In this weekly roundup of research and development activity in North Texas, you'll also find out about how a professor at UNT is developing a wireless, wearable fitness tracker that won't need to be charged.
MORE►
by Heather Noel |
Jul 27, 2017
A group of North Texas investors made up a major portion of the Series A round.
MORE►
